Plus, news about Orion, Stalicla, Cyrano Therapeutics and Instil Bio: Jennifer Doudna’s latest venture: Her lab published a study Thursday in Nature Biotechnology detailing how antibody fragments can be used to target virus-like particles with gene editing ma…